FDA's insights: implementing new strategies for evaluating drug-induced QTc prolongation
Crossref DOI link: https://doi.org/10.1007/s10928-025-09985-4
Published Online: 2025-06-25
Published Print: 2025-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Ji, Yanyan
Johannesen, Lars
Garnett, Christine
Text and Data Mining valid from 2025-06-25
Version of Record valid from 2025-06-25
Article History
Received: 10 January 2025
Accepted: 4 June 2025
First Online: 25 June 2025
Declarations
:
: The authors declare no competing interests.